Product Information
DICLOFENAC SODIUM 1% GEL is a generic product labeled by BluePoint Laboratories, priced at $0.0813 per GM under NDC 68001062145. Its NADAC has been published 70 times since Jun 4, 2025.
FDA first approved this application on Jan 27, 2020.
Strength
10 mg/g
Manufacturer
BluePoint LaboratoriesNDC
68001062145
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA210986FDA Approved
1/27/2020
On Market Since
5/17/2025
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC SODIUM 1% GEL has been published 70 times since Jun 4, 2025, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0813 per GM |
|---|---|
| All-time high | $0.0953 (Jan 14, 2026) |
| All-time low | $0.0813 (Sep 23, 2026) |
| 52-week high | $0.0953 |
| 52-week low | $0.0813 |
| Median price | $0.0904 |
| Average price | $0.0898 |
| Largest weekly change | +2.8% (Oct 22, 2025) |
| Weeks tracked | 70 |
| Tracking since | Jun 4, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diclofenac Sodium Topical Gel, 1% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Sodium Topical Gel, 1% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC SODIUM 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC SODIUM 1% GEL, manufactured by BluePoint Laboratories, is $0.0813 per GM (NDC 68001062145), effective Sep 30, 2026.
How has the price of DICLOFENAC SODIUM 1% GEL changed over time?
Over the history we have for it, the NADAC for DICLOFENAC SODIUM 1% GEL has declined 11.7%. It has been tracked across 70 weekly CMS publications since Jun 4, 2025.
What are the highest and lowest recorded NADAC prices for DICLOFENAC SODIUM 1% GEL?
Since Jun 4, 2025, the NADAC for DICLOFENAC SODIUM 1% GEL has ranged from a low of $0.0813 (Sep 23, 2026) to a high of $0.0953 (Jan 14, 2026), with a median of $0.0904 per GM.
Are there cheaper alternatives to DICLOFENAC SODIUM 1% GEL?
No other NADAC-published product currently shares the active ingredient and strength of DICLOFENAC SODIUM 1% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DICLOFENAC SODIUM 1% GEL?
DICLOFENAC SODIUM 1% GEL (NDC 68001062145) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.